Intranasal

Preliminary Data Show that Oxytocin Decreases Impulsivity and Reduces Food Intake TNX-1900 (Intranasal Potentiated Oxytocin) May Serve as a Novel Neuroendocrine Treatment for Binge-Eating…

CHATHAM, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company, today announced that the first participant has been…

SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better…

Results confirm positive signal previously reported in the first two Expanded Access patients who both subsequently demonstrated clinical improvementsPhase 2a trial in na-SPMS on track to…

Elana Gotkine FRIDAY, June 2, 2023 (HealthDay News) -- Intranasal ketamine seems effective for refractory chronic migraine, with about half of…

<!-- Name:DistributionId Value:8837977 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8783993 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

Intranasal corticosteroids (INCs) improved quality of life for children suffering from…

<!-- Name:DistributionId Value:8742817 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

…